Jubilant Life Sciences shares rallied nearly 8 percent after stellar earnings performance.
Consolidated net profit during October-December quarter grew sharply by 78 percent to Rs 212.5 crore compared to Rs 119.4 crore in year-ago.
Revenue from operations surged 41.8 percent year-on-year to Rs 2,067.8 crore while operating profit jumped 25.6 percent to Rs 416.8 crore, but margin contracted 260 basis points to 20.2 percent in Q3.
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
You may also like:
|Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited||Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed|